"Altasciences est une entreprise de recherche contractuelle reconnue à l’international et spécialisée dans les essais cliniques de bioéquivalence et de Phase I/Ila. Les bureaux d'Altasciences au 1100 Beaumont s'occupent des rencontres médicales des participants et de la prise de rendez-vous. Du personnel est toujours sur place pour répondre à toutes questions sur les études, notre entreprise et la recherche clinique."

During the past decade, Algorithme Pharma. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Algorithme Pharma." #1 sponsor was "Mylan Pharmaceuticals Inc" with 4 trials, followed by "Par Pharmaceutical, Inc." with 3 trials sponsored, "JDP Therapeutics, Inc." with 2 trials sponsored, "Novartis" with 2 trials sponsored and "Antibe Therapeutics Inc." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Algorithme Pharma." #1 collaborator was "Algorithme Pharma Inc" with 6 trials as a collaborator, "Genpharm ULC" with 4 trials as a collaborator, "Novartis Consumer Health" with 2 trials as a collaborator and "Locemia Solutions ULC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Algorithme Pharma." are "Healthy" (7 trials), "Acute Urticaria" (2 trials), "Upper Respiratory Infections" (2 trials), "Chronic Hepatitis B" (1 trials) and "Chronic Pain" (1 trials). Many other conditions were trialed in "Algorithme Pharma." in a lesser frequency.

Most popular intervention types in "Algorithme Pharma." are "Drug" (15 trials), "Combination Product" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Clarithromycin" (3 trials), "Ondansetron" (2 trials), "Placebo" (2 trials), "ATB-346" (1 trials) and "Baclofen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Algorithme Pharma." are 16 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Algorithme Pharma.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Algorithme Pharma., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Algorithme Pharma., 13 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".